Andra AP-fonden’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Sell
48,030
-54,650
-53% -$16.2M 0.17% 149
2025
Q4
$28M Sell
102,680
-42,620
-29% -$11.6M 0.35% 82
2025
Q3
$39.3M Buy
145,300
+77,100
+113% +$21M 0.5% 48
2025
Q2
$18.8M Buy
+68,200
New +$18.5M 0.26% 130
2025
Q1
Sell
-18,700
Closed -$4.34M 474
2024
Q4
$4.34M Buy
18,700
+2,100
+13% +$483K 0.07% 299
2024
Q3
$3.66M Sell
16,600
-26,200
-61% -$5.42M 0.05% 327
2024
Q2
$8.41M Buy
42,800
+34,900
+442% +$7.21M 0.14% 229
2024
Q1
$1.7M Sell
7,900
-28,200
-78% -$5.92M 0.03% 342
2023
Q4
$7.6M Buy
36,100
+4,900
+16% +$1.05M 0.4% 115
2023
Q3
$6.25M Buy
31,200
+1,600
+5% +$318K 0.37% 122
2023
Q2
$5.48M Buy
29,600
+1,300
+5% +$240K 0.14% 350
2023
Q1
$5.42M Sell
28,300
-6,600
-19% -$1.19M 0.14% 321
2022
Q4
$5.87M Sell
34,900
-3,100
-8% -$539K 0.18% 259
2022
Q3
$6.73M Buy
38,000
+16,100
+74% +$3.18M 0.22% 183
2022
Q2
$4.48M Buy
+21,900
New +$4.64M 0.13% 363
2021
Q4
$6.12M Sell
26,800
-9,500
-26% -$2.09M 0.12% 370
2021
Q3
$7.02M Sell
36,300
-6,000
-14% -$1.22M 0.14% 344
2021
Q2
$9M Buy
42,300
+800
+2% +$169K 0.18% 243
2021
Q1
$8.48M Sell
41,500
-5,800
-12% -$1.14M 0.19% 237
2020
Q4
$8.61M Sell
47,300
-14,300
-23% -$2.43M 0.19% 229
2020
Q3
$10.3M Buy
61,600
+12,900
+26% +$2.17M 0.28% 58
2020
Q2
$7.92M Buy
48,700
+11,800
+32% +$2.12M 0.23% 80
2020
Q1
$6.38M Buy
36,900
+10,900
+42% +$2.17M 0.23% 55
2019
Q4
$5.22M Buy
26,000
+300
+1% +$61.5K 0.15% 349
2019
Q3
$5.43M Buy
25,700
+1,300
+5% +$272K 0.16% 304
2019
Q2
$4.74M Sell
24,400
-2,200
-8% -$406K 0.14% 394
2019
Q1
$4.38M Buy
+26,600
New +$4.7M 0.13% 426
2018
Q3
$6.01M Sell
35,300
-6,800
-16% -$1.14M 0.15% 304
2018
Q2
$6.9M Buy
42,100
+2,600
+7% +$425K 0.19% 198
2018
Q1
$6.39M Sell
39,500
-29,156
-42% -$4.64M 0.17% 268
2017
Q4
$10M Sell
68,656
-11,044
-14% -$1.57M 0.23% 123
2017
Q3
$10.8M Buy
79,700
+11,900
+18% +$1.5M 0.25% 107
2017
Q2
$8.49M Buy
67,800
+2,400
+4% +$287K 0.21% 134
2017
Q1
$7.77M Sell
65,400
-3,000
-4% -$361K 0.18% 142
2016
Q4
$7.89M Buy
68,400
+28,800
+73% +$3.2M 0.22% 126
2016
Q3
$4.14M Sell
39,600
-5,300
-12% -$553K 0.11% 288
2016
Q2
$4.37M Buy
44,900
+4,800
+12% +$454K 0.11% 262
2016
Q1
$3.85M Sell
40,100
-4,900
-11% -$446K 0.1% 302
2015
Q4
$4.08M Buy
45,000
+5,500
+14% +$518K 0.12% 251
2015
Q3
$3.66M Sell
39,500
-4,600
-10% -$437K 0.11% 280
2015
Q2
$4.1M Buy
44,100
+8,400
+24% +$784K 0.12% 263
2015
Q1
$3.38M Sell
35,700
-2,900
-8% -$269K 0.1% 325
2014
Q4
$3.42M Buy
38,600
+33,100
+602% +$2.8M 0.08% 365
2014
Q3
$440K Hold
5,500
0.01% 536
2014
Q2
$390K Sell
5,500
-52,200
-90% -$3.67M 0.01% 552
2014
Q1
$4.27M Buy
57,700
+17,200
+42% +$1.3M 0.1% 336
2013
Q4
$3.18M Buy
40,500
+4,400
+12% +$345K 0.08% 371
2013
Q3
$2.67M Buy
36,100
+15,300
+74% +$1.13M 0.07% 385
2013
Q2
$1.58M Buy
+20,800
New +$1.36M 0.04% 452

Other funds holding CME

Andra AP-fonden's CME Position: Q1 2026 in Review

Andra AP-fonden reduced its CME Group (CME) stake by 53% in Q1 2026, selling an estimated $16.2M and leaving 48,030 shares worth $14.2M. The position accounts for 0.17% of the portfolio, ranked #149.

Andra AP-fonden first reported a position in CME in Q2 2013 and has held it in 49 quarters since. The position peaked at $39.3M in Q3 2025. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Andra AP-fonden held 48,030 shares of CME Group worth $14.2M as of Q1 2026.
  • Andra AP-fonden sold 54,650 CME Group shares in Q1 2026, an estimated $16.2M.
  • CME Group made up 0.17% of Andra AP-fonden's portfolio in Q1 2026, its #149 holding.
  • Andra AP-fonden first reported a position in CME Group in Q2 2013 and has held it in 49 quarters since.
  • Andra AP-fonden's CME Group position peaked at $39.3M in Q3 2025.
  • 1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.